 Intra-Cellular Therapies NASDAQ:ITCI and IMMURON LTDS NASDAQ:IMRN are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Volatility and Risk Intra-Cellular Therapies has a beta of 1.91, suggesting that its stock price ... 